Christina Szalinski Lung cancer is the deadliest cancer in the world, largely because so many patients are diagnosed late. Screening more patients could help, yet screening rates remain critically low. In the United States, only about 6% of eligible people get screened , according to the American Lung Association. Contrast that with screening rates for...
Lung cancer is the deadliest cancer in the world, largely because so many patients are diagnosed late. Screening more patients could help, yet screening rates remain critically low. In the United States, only about 6% of eligible people get screened , according to the American Lung Association. Contrast that with screening rates for breast, cervical,...
Neil Osterweil A simple urine test for genetic mutations in urine-derived DNA can predict urothelial cancer up to 12 years before patients develop symptoms, an international team of researchers claims. The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder cancer...
JUNE 6TH, 2023 CONN HASTINGS DIAGNOSTICS, MEDICINE, NEUROLOGY Scientists at Purdue University have developed a urine test for early-stage Parkinson’s disease. The technology involves isolating extracellular vesicles of neural origin from urine samples and then assessing the proteins within the vesicles to detect biomarkers of the disease. The researchers have called their technology “EVtrap” (Extracellular Vesicles total recovery...
MAY 9TH, 2023 CONN HASTINGS DIAGNOSTICS, GENETICS, ONCOLOGY Researchers at MIT have developed a urine test that can distinguish between different types of cancer, and could even highlight if metastases are present. The test involves first administering nanoparticles to patients that can circulate around their blood before encountering a tumor. Enzymes that are overexpressed by the tumor...
Neil Osterweil March 13, 2023 A simple urine test for genetic mutations in urine-derived DNA can predict urothelial cancer up to 12 years before patients develop symptoms, an international team of researchers claims. The test, if validated in further studies, has the potential to serve as a cancer screening tool for individuals at elevated risk for bladder...
by University of Glasgow Credit: Unsplash/CC0 Public Domain New research, led by the University of Glasgow and published in the British Journal of General Practice, assessed patient data from across the U.K. and found that not enough people with chronic kidney disease were routinely being given this recommended test. The study results have prompted renewed calls...
by University of Birmingham Mutation frequencies across incident bladder cancer stages and grades. Data are shown for the six genes most frequently mutated (overall) in grade 1 pTa (n = 23), grade 2 pTa (n = 42), grade 3 pTa (n = 15), grade 3 pT1 (n = 24), and grade 2 pTa (n =...
Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a simple test for protein in the urine to screen for this potentially deadly disorder, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health. The researchers analyzed data on nearly four million...
By Michael Irving July 15, 2021 MIT researchers have developed nanoparticles that can reveal cancer through a urine test, and in follow-ups pinpoint its location in the bodygofkein/Depositphotos The earlier cancer is detected, the better the outcome for the patient. Now, researchers at MIT have developed a new diagnostic system that can be performed as a simple...
